Spread the love

Cell therapy is not a solution to all prevailing health problems.

  • Each individual responds differently; the key purpose of this process is to give tools to the body and generate ideal conditions to produce impaired tissue by itself. Previous experiences and procedures show a remarkable improvement in the majority of patients while other patients might not show considerable improvement.
    The result of any procedure depends on the patient’s specific body retrieval ability.
  • Every participant’s body might react in a diverse way, thus we cannot generalize a therapy and a result, the following is a short list of ailments on which we have gotten the best results.
  • There is no standard process for all patients. Nonetheless, below we have displayed conditions with the finest results for improvement, centered on our own clinical outcomes. We are updating our list as new outcomes and technology become accessible.

There are 2 imperative limitations to cell therapy.

  • If stem cell production in the bone marrow is low, then the quantity of cells harvested is limited instigating a poor transfusion with a low number of cells. Even though cells have the chemical capability to detect damaged tissue, there might be a physical impediment (like a blocked artery) that will not permit these stem cells to travel to damaged areas. If the reason of the obstruction is not eliminated, there will be poor, slow or no tissue regeneration.
  • The second hindrance is related to dearth of medical knowledge in regards to cancer. Adding progenitor cells could have a potential negative effect in the body via a spurt of tumor growth. Thus, cell therapy for cancer conditions, these days, necessitates greater knowledge and studies. At this time, our protocol is restricted to diseases excluding cancer.Quality of stem cells is tremendously imperative. Older patients have less competence for stem cell production in the bone marrow than younger patients. Patients older than 74 years have less likelihood of producing a high level of stem cells.